August 2025 Extended Echo Session: Non-sputum-based tests for TB: hype or hope?
7 August 2025 Every year, an estimated 3 million people with TB go undiagnosed due to limited access to quality diagnostics, weak health systems and reliance on sputum samples. Non
July 2025 LabCoP Extended ECHO Session: Practical Approaches to tNGS Implementation for Rapid Detection of Drug-Resistant TB: Insights from West Java, Indonesia
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
July 2025 AMR CoP ECHO Session: Success Stories and Challenges in Implementing Infection Prevention and Control (IPC) in Resource-Limited Settings
As we continue to confront the growing threat of antimicrobial resistance, Infection Prevention and Control (IPC) remains one of the most powerful and cost-effective interventions
June 2025 AMR CoP ECHO Session: Simplifying AMR Surveillance by Building Expertise Alongside Automated AMR/C/U Analysis through Africa’s Knowledge
This AMR CoP ECHO session focuses on simplifying AMR surveillance by building expertise alongside automated AMR/C/U analysis through Africa’s Knowledge Hub. This session demonstr
June 2025 LabCoP Extended ECHO Session: Flying blind: the urgent need for rapid detection of bedaquiline-resistant TB
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
June 2025 Science Webinar: From Lab to Market Place: ABCs of Diagnostic Product Development
The ASLM Science and Innovation Webinar Series aims to provide a platform for the latest scientific advancements, knowledge sharing, and skill enhancement for laboratory medicine p
June 2025 LabCoP Extended ECHO session: Making Genomics Work for TB: Practical and Cost-Effective Use of tNGS in TB Programs
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended ECHO Session: Experiences, challenges and lessons learnt in improving the public health laboratories surveillance capabilities for priority diseases The experiences of Burkina Faso, and São Tomé and Príncipe
In this ECHO session,São Tomé and Príncipe, and Burkina Faso shares their experiences, challenges, lessons learnt and priority areas in improving detection, surveillance and res
